Jpmorgan Chase & Co »

Avalo Therapeutics Ord shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-06-30 $25 2 12.50
2024-03-31 $44 2 22.00
2023-12-31 $18 2 9.00

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf (SPY)
Meta Platforms Common (META)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Broadcom Common (AVGO)
Alphabet Common (GOOGL)
Vanguard Total Intl Bond Etf Fund (BNDX)
Vanguard S&p 500 Etf idx (VOO)
Ishares Core S&p 500 Etf Fund (IVV)

View all positions for Jpmorgan Chase & Co

Top funds holding Avalo Therapeutics Ord

Logos Global Management
Sio Capital Management
Ikarian Capital
Affinity Asset Advisors
Commodore Capital
Vanguard Group
Bank of America Corporation
Royal Bank of Canada
Banque Cantonale Vaudoise
BlackRock
Morgan Stanley
Efficient Wealth Management
Bnp Paribas Arbitrage, Snc
Group One Trading
Jpmorgan Chase & Co

View all funds holding Avalo Therapeutics Ord